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The potential for in vitro colonization of decellularized valves by human bone marrow mesenchymal
stem cells (hBM-MSCs) towards the anisotropic layers ventricularis and ﬁbrosa and in homo- vs.
heterotypic cell–ECM interactions has never been investigated. hBM-MSCs were expanded and charac-
terized by immunoﬂuorescence and FACS analysis. Porcine and human pulmonary valve leaﬂets (p- and
hPVLs, respectively) underwent decellularization with Triton X100–sodium cholate treatment (TRICOL),
followed by nuclear fragment removal. hBM-MSCs (2 106 cells/cm2) were seeded onto ﬁbrosa (FS) or
ventricularis (VS) of decellularized PVLs, precoated with FBS and ﬁbronectin, and statically cultured for 30
days. Bioengineered PVLs revealed no histopathological features but a reconstructed endothelium lining
and the presence of ﬁbroblasts, myoﬁbroblasts and SMCs, as in the corresponding native leaﬂet. The two
valve layers behaved differently as regards hBM-MSC repopulation potential, however, with a higher
degree of 3D spreading and differentiation in VS than in FS samples, and with enhanced cell survival and
colonization effects in the homotypic ventricularis matrix, suggesting that hBM-MSC phenotypic
conversion is strongly inﬂuenced in vitro by the anisotropic valve microstructure and species-speciﬁc
matching between extracellular matrix and donor cells. These ﬁndings are of particular relevance to
in vivo future applications of valve tissue engineering.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Among heart diseases, end-stage valvulopathy still represents
a condition for which valve replacement with mechanical or bio-
logical prostheses is mandatory [1,2]. Xeno- and homograft biolo-
gical supports are currently used in cardiac surgery and both have
their pros and cons as regards durability and performance, particu-
larly in pediatric patients with congenital heart defects (i.e. Fallot’s
tetralogy) [3]. The fact that current biological valve prostheses do not
enable the reconstitution of a viable valve structure has prompted
new bioengineered applications based on decellularized valvetalitate Exornatum Succeda-
39 049 812410; fax: þ39 049
All rights reserved.scaffolds seeded with autologous cells from the recipient prior to
implantation, or recolonized in vivo after surgery. Basically, this two-
step procedure includes preparing xeno- or homogeneic valve
matrices [4] with mechanical and functional properties suitable for
cell engraftment. We recently set up a technique for decellularizing
porcine heart valve leaﬂets using a non-ionic detergent, Triton X100,
which enables scaffolds with an optimally preserved collagenous-
elastic network to be achieved [5,6]. It is particularly important to
select cell type(s) suitable for an appropriate valve cell colonization
in vitro in static conditions or in a bioreactor. Ideally, the recon-
stituted valve should display an endocardial endothelium covering
the engineered tissue and valve interstitial cells (VICs) distributed
tissue-speciﬁcally, i.e. myoﬁbroblasts and smooth muscle cells
(SMCs) in the ventricularis, and ﬁbroblasts in the ﬁbrosa and spon-
giosa layers [7]. To achieve this result, researchers beneﬁted from
more mature cells, as myoﬁbroblasts [8], endothelial cells (ECs),
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types, i.e. endothelial progenitor cells (EPCs), or mesenchymal stem
cells (MSCs) [10–12]. Among the various cells tested, MSCs obtained
from bone marrow (BM-MSCs) offer some advantages over other
stem or progenitor cells in terms of their prospects for employ in
routine clinical practice, i.e. simple protocols for their isolation,
storage and in vitro expansion [13], a surprising phenotypic resem-
blance to valve cells [14], a beneﬁcial immunomodulatory capacity
[15] and, in a more signiﬁcant way, they can be phenotypically
converted into ECs, ﬁbroblasts/myoﬁbroblasts, and SMCs [16–18].
So far, efforts to obtain valve substitutes with biomaterial
moulds populated with extra-valve cells have failed to recreate the
ﬁber arrangement of native matrix. This drawback can be overcome
by using decellularized scaffolds, which act as ideal supports for cell
attachment and differentiation because the native leaﬂet ﬁber
integrity and alignment are preserved [5,6,19], as demonstrated by
recolonizing valve scaffolds with VICs [4]. In this study, we ﬁrst
investigated cell adhesion, spreading and potential for differentia-
tion of hBM-MSCs seeded statically onto the two anisotropic
microstructures of ventricularis and ﬁbrosa of porcine valve leaﬂets.
After establishing which of the two valve layers was better able to
allocate hBM-MSCs, we compared these cells in a hetero- vs.
homotypic matrix setting, using decellularized porcine and human
valve leaﬂets, respectively. The results of this study are of impor-
tance to clinical applications of valve tissue engineering, and
particularly to the assessment of whether a xenomatrix seeded
with patient’s cells can surrogate an autologously cell-colonized
allomatrix as a valve substitute.
2. Experimental
2.1. Human bone marrow mesenchymal stem cells (hBM-MSCs)
Bone marrow obtained under local anesthesia from the iliac crest of healthy
young voluntary donors (15–30 years old) was diluted with sterile Ficoll (1:2;
Lymphoprep). After centrifugation (1040 rpm, 5 min, RT), collected pellets were
resuspended in a-MEM (Sigma, St. Louis, MO) plus 20% fetal bovine serum (FBS,
Invitrogen, Carlsbad, CA), 1% penicillin–streptomycin (Sigma) and 1% L-glutamine
(200 mM; Sigma), and plated on non-tissue culture plates (NOTC; BD Falcon, BD
Biosciences, Franklin Lakes, NJ). Non-adherent cells and debris were discarded after
seven days. Adherent cells were cultured until pre-conﬂuence, then detached from
plastic using a 0.05% trypsin–sodium EDTA solution (Sigma), and passaged up to the
4th passage. Cell morphology was studied using a phase contrast Leica DM IRB
microscope (Leica, Wetzlar, Germany) connected to a Canon Power Shot S40 camera.
2.2. Flow cytometry and cytocentrifugation
FACS analysis of hBM-MSCs was performed at the 3rd passage. Cells, detached
with citrate buffer (Sigma), rinsed and re-suspended in PBS, pH 7.2 (Sigma) at
a concentration of 5105 cells/100 ml, were directly stained with 10 ml of FITC
ﬂuorochrome-labeled anti-human HLA-ABC (Immunotech, Marseille, France), CD29
(Immunotech), CD44 (Immunotech), CD90 (Immunotech), CD146 (Immunotech),
CD31 (Immunotech) and PE-conjugated anti-human antibodies to the progenitor
markers CD45 (Immunotech), CD34 (Immunotech), CD117 (Immunotech), HLA-DR
(Immunotech), CD73 (BD Biosciences), and CD105 (Beckman Coulter, Fullerton, CA).
Cytometric analysis was done using a COULTER Epics XL-MCL cytometer (Beckman
Coulter) and data were processed using EXPO 32 ADC software.
Cytocentrifuged cell samples, acquired via a Shandon Cytospin 4 centrifuge
(Thermo Fisher Scientiﬁc, Inc., Waltham, MA), were ﬁxed in 2% p-formaldehyde in
PBS and incubated with primary antibodies to membrane and cytoplasmic antigens
of differentiated valve cells as well as embryonic and mesenchymal stem cell anti-
gens, for 30 min at 37 C. The primary antibodies used in the immunoﬂuorescence
experiments were directed against the following epitopes: SSEA4 (Chemicon,
Temecula, CA), OCT3/4 (Santa Cruz, Santa Cruz, CA), human CD117 (Dako, Dakopatts,
Denmark), human CD34 (Dako), human CD133 (Abcam, Cambridge, UK), human
CD90 (Chemicon), CD271 (NGFr; BD Biosciences), human CD29 (Integrin b1;
Chemicon), human CD105 (Cymbus, Chandlers Ford, UK), Stro1 (Developmental
Studies Hybridoma Bank, Iowa City, Iowa), CD54 (ICAM1; Sigma), Flk1 (VEGF-R2;
Santa Cruz), human nestin (Abcam), glial ﬁbrillary acidic protein (GFAP, Chemicon),
von Willebrand factor (vWf; Dako), SM a-actin (Sigma), SM22 (Abcam), vimentin
(clone V9, Dako), platelet myosin heavy chains (MyHC-Apla1 and MyHC-Apla2) [20],
SM-myosin heavy chain II (SM-MyHC) [20], smoothelin (Abcam), osteopontin
(Abcam), osteocalcin (Abcam), osteonectin (clone AON, Hybridoma Bank), tenascin(Exalpha, Maynard, MA), pro-collagen I (clone M38, Hybridoma Bank), human
aggrecan (not reactive to porcine aggrecan; Abcam), HLA-ABC (Chemicon) and MHC
II (VMRD, Inc., Pullman, WA). The secondary antibodies were the Cy2 conjugated
goat Fab’ to mouse or rabbit IgGs (Chemicon). Cell nuclei were stained with Hoechst
(Hoechst 33258; Sigma). Antigen distribution was studied using a Zeiss Axioplan
epiﬂuorescence microscope (Zeiss, Oberkochen, Germany) and images were
acquired using a Leica DC300F digital videocamera (Leica, Wetzlar, Germany). The
cytocentrifuged cells positive to each antibody were counted manually by two
independent examiners and the corresponding scores were expressed as percent-
ages of total Hoechst-stained cells.
Flow cytometry and cytocentrifugation analyses were performed in triplicate
using distinct MSC preparations.
2.3. Endothelial, smooth muscle, adipogenic and osteogenic differentiation
of hBM-MSCs
Cell lineage differentiation was assessed by stimulating passaged cells with
induction media speciﬁc for ECs (Endothelial cell growth medium; PromoCell,
Heidelberg, Germany) and SMCs (DMEMwith 10% FBS, 5% horse serum [Invitrogen],
and 50 mM hydrocortisone [Sigma]), which normally populate heart valve leaﬂets.
Adipogenic and osteogenic conversion abilities were also investigated. Brieﬂy, cells
were plated at a density of 4103 cells/cm2 on tissue culture dishes (Falcon, BD) and
treated with: (1) adipogenic medium (low-glucose DMEM supplemented with 10%
FBS, 1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, 10 mM insulin,
200 mM indomethacin [Sigma]); and (2) osteogenic medium (low-glucose DMEM
supplemented with 100 nM dexamethasone, 10 mM b-glycerol phosphate, 50 mM
ascorbic acid 2 phosphate [Stem Cell Technologies Inc., Vancouver, BC]). Each
stimulation lasted 21 days with medium changes 3 times a week.
Coverslips with treated hBM-MSCs were ﬁxed in 2% p-formaldehyde in PBS and
tested in immunoﬂuorescencewith anti-vWf, anti-CD31, anti-SM a-actin, anti-SM22
and anti- SM-MyHC as primary antibodies; mouse or rabbit Cy2 conjugated-IgGs as
secondary ones and Hoechst for nuclear staining. Adipogenic induction was deter-
mined by evaluating cells with fat vesicles, stained by Oil-Red-O staining (Sigma).
Alkaline phosphatase (AP; Sigma) was used to visualize the effects of osteogenic
stimulation. Nuclei were counterstained with Mayer’s hematoxylin (Sigma).
Antigen distribution was evaluated using a Leica light microscope and images
were acquired with a Leica DC300 digital videocamera (Leica).
2.4. Heart valve leaﬂets and decellularization procedures
Porcine pulmonary valve leaﬂets were used to study the effect of matrix ﬁber
distribution on cell attachment. Porcine hearts (n¼ 2) were harvested under sterile
conditions from a local abattoir and stored at þ4 C until further processing. In the
presence of protease inhibitors, pulmonary heart valves were isolated in aseptic
conditions and decellularized according to Spina et al. [6]. Brieﬂy, the leaﬂets (n¼ 4)
were treated with solutions containing Triton X100 and sodium cholate (TRICOL) in
a nitrogen atmosphere. An endonuclease treatment (Benzonase, Merck, Darmstadt,
Germany) was applied to remove any remaining nuclear fragments. All solutions
used in the procedure were degassed and ﬁltered in sterile conditions (0.22 mm-
ﬁlter; Millipore).
Serologically-tested, intact cryopreserved human pulmonary heart valves
(n¼ 2) were obtained from the Tissue Bank of Treviso Hospital. Human leaﬂets
(n¼ 4) were decellularized using the same protocol as for porcine matrices.
For each preparation, a sample was removed and snap-frozen in OCT (Tissue Tek,
Tokyo, Japan) to verify effective cell and nuclear debris removal. For this purpose, 6 mm-
cryosections underwent Hoechst staining to identify nuclear fragments, and hema-
toxylin and eosin staining (Bio-Optica, Milan, Italy) to additionally reveal cell debris.
Alpha-gal xenoantigen expression was also assessed in porcine leaﬂets by
double immunoﬂuorescence using an FITC-conjugated B4 isolectin from Bandeiraea
simplicifolia (BSI-B4; Griffonia simplicifolia, Sigma) and a speciﬁc monoclonal anti-
body (M86, Axxora, Nottingham, UK), revealed with an AlexaFluor 594-conjugated
goat Fab’ to mouse immunoglobulins (Molecular Probes, Carlsbad, CA). Native
porcine leaﬂets were used as positive controls.
2.5. In vitro static cell seeding
Eachdecellularized leaﬂetwasdivided into twoparts (pigpulmonaryvalve leaﬂets,
pPVLs, n¼ 8; human pulmonary valve leaﬂets, hPVLs, n¼ 8) and stored for 7 days in
a 0.04% sodium azide solution (NaN3; Sigma) in PBS. After intensive washout with
a sterile 5% sodium carbonate solution (Prolabo, Paris, France) to completely remove
any residual NaN3, leaﬂets were subjected to a combined antibiotic–antimycotic
treatment for four days. The cocktail contained lyncomycin (600 mg/ml; Lincocin,
Pharmacia Italia, Milano, Italy), vancomycin (250 mg/ml; Vanco, Bayer, Milan, Italy),
cephazolin (1200 mg/ml; Cefazolina, Dorom, Milano, Italy), colymicin (500 mg/ml; Col-
imicina, UCB Pharma, Torino, Italy) and amphothericin B (5 mg/ml; Fungizone, Bris-
tol-Myers Squibb, UK), and was replaced every 24 h. Any residual antibiotic solution
was removed bywashing out in HEPES-modiﬁed DMEM (Sigma). PVLs were incubated
with this medium for 24 h at 37 C in a humidiﬁed atmosphere, then treated with FBS
(12 h at 37 C), followed by bovine ﬁbronectin (5 mg/cm2; 24 h at 37 C; Sigma).
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pPVL were placed in tissue culture 24-wells (TC; Falcon BD) and seeded respectively
onto ﬁbrosa (ﬁbrosa-seeded, FS) or ventricularis (ventricularis-seeded, VS) with hBM-
MSCs (2.0106/cm2), previously collected by trypsin–EDTA treatment, centrifuged
and resuspended in HEPES-modiﬁed DMEM plus 10% FBS, 1% streptomycin–peni-
cillin and 1% L-glutamine. After cell seeding onto these surfaces, in vitro engineered
constructs were maintained for 30 days at 37 C in humidiﬁed atmosphere,
changing the medium every 3 days. Seeded leaﬂets were subsequently embedded in
OCT, snap-frozen in liquid nitrogen and stored at 80 C.
In the second part of experiments, hBM-MSCs were seeded onto hPVLs applying
the same procedure as for porcine valve scaffolds.
2.6. Tissue analysis and quantitative studies on bioengineered leaﬂets
Cryostatic sections (6–7 mm) were stained with hematoxylin and eosin, Mas-
son’s trichrome (to study ECM composition), and von Kossa (to evaluate any calcium
deposits). Adhered hBM-MSCs were analyzed for the expression of any differenti-
ation antigens pertinent to valve cell lineages and stem cell epitopes, using anti-
bodies to: pro-collagen I, collagen I (Sigma), collagen III (Chemicon), elastin (Sigma),
vimentin, SM a-actin, smoothelin, MyHC-Apla1, MyHC-Apla2, SM-MyHC, SM22, vWf,
human CD31 (Dako), CD133, CD34, CD117, CD105, nestin, GFAP, CD90, Flk1, OCT3/4,
SSEA4, osteopontin and osteocalcin. HRP-conjugated anti-mouse and anti-rabbit
IgGs (Dako) were used as secondary antibodies. The substrate used to reveal the
bound primary antibodies was 3-amino-9-ethylcarbazole (Sigma). Controls were
obtained using non-immune IgGs instead of the primary antibodies. Nuclei were
counterstained with Harris’s hematoxylin (Sigma).
Cell counting was performed using double immunoﬂuorescence with FITC-
conjugated, anti-SM a-actin (Sigma) and other primary antibodies (vWf and CD31
for ECs; MyHC-Apla1 for ﬁbroblasts; SM22 and SM-MyHC for SMCs; osteopontin,
osteocalcin for pro-calciﬁc cytotypes; pro-collagen I and aggrecan [applied to PFA-
ﬁxed, chondroitinase-treated sections] for neo-synthesized matrix elements; SSEA4
and OCT4 for stem cells). Primary antibody binding was revealed with AlexaFluor
594-conjugated goat Fab’ to mouse and rabbit IgGs (Molecular Probes).
Apoptosis and proliferation were analyzed in epiﬂuorescence microscopy using
ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit (Chemicon) and anti-
phospho-Histone H3 antibody (Ser 10; Upstate, Lake Placid, NY), respectively.
Attachment, cell spreading and phenotypic expression of colonizing cells were
examined in a blinded fashion by randomly choosing four microscopic ﬁelds in three
sections for each tissue at 400 magniﬁcation (corresponding to an area of
0.0374 mm2).
2.7. Transmission electronic microscopy on repopulated PVLs
Specimens of about 1 mm3 were ﬁxed with 2.5% formaldehyde–2.5% glutaral-
dehyde in 0.1 mol/L phosphate buffer, pH 7.2, post-ﬁxed with 2% OsO4 in the same
buffer, dehydrated with graded ethanols and embedded in Araldite/Epon. Thin
sections were contrasted with uranyl acetate and lead citrate. Observations and
photographic records were obtained with a Philips CM12 STEM electron microscope
(Philips Export BV, Eindhoven, Holland).
2.8. Statistical analysis
Data are expressed asmeans SD. Statistical differences between FS and VS, and
between pig-VS and human-VS specimens, were determined using Student’s paired
or unpaired t-tests. Results were considered statistically signiﬁcant if p< 0.01.
3. Results
3.1. Immunophenotypic characterization and phenotypic
conversion potential of hBM-MSCs
hBM-MSCs, collected by density gradient centrifugation and
selected for plastic adherence, displayed a typical spindle-shaped
morphology in vitro (Fig. 1A, panel a) with a tendency to grow in
multilayered clusters (Fig. 1A, panel b [inset a]). Cells were charac-
terized by ﬂow cytometry (Fig. 1B) and cytocentrifugation (Table 1),
revealing a ‘‘classical’’ pattern of ‘‘mesenchymal stemness’’,
conﬁrmed by a high expression for some characteristic markers, e.g.
CD73, CD105, CD29, CD44, CD90. The hematopoietic antigens CD45,
CD34 and CD117 were negative or expressed at very low levels by
hBM-MSCs. Only a small fraction of the cell preparationswas reactive
for HLA-DR (one of the trigging elements of immune rejection in cell
transplants), while HLA-ABC, which is essential to immune modu-
lation, was shared by a large majority. Other stem cell markers, suchas OCT3/4, SSEA4, Nestin, GFAP, NGFr, Flk1 and Stro1, analyzed by
immunoﬂuorescence on cytocentrifuged, were also positive. The
presence of CD146 is compatible with an endothelial-pericyte
commitment and in contrastwith the absence ofmature ECproteins,
i.e. vWf and CD31. An early differentiating SMC proﬁle could also be
demonstratedgiven theweakpositivity for the lineage-speciﬁcSM22
andSMa-actin,but themost committed smoothmuscleproteinsSM-
MyHC and smoothelin were almost not found. A wide immunode-
tection of MyHC-Apla1, MyHC-Apla2 and vimentin endorses the
description of a typical ﬁbroblastic phenotype. Despite a relevant
osteopontin display, the pattern for bone markers was substantially
negative for the more mature osteogenic proteins, osteocalcin,
osteonectin and tenascin.
Cell treatmentwith speciﬁc inducingmedia gave rise to different
degrees of adipogenic, EC and SMC conversion: there was a roughly
90-fold increase in CD31 immunoexpression (77.56 4.78%; Fig.1C,
panel a) and vWf enhanced about 6 times (97.611.07%; Fig. 1C,
panel b), comparedwith the untreated condition, while the smooth
muscle markers SM a-actin, SM22 and SM-MyHC were augmented
in proportions of 20.69 5.04, 63.20 2.71 and 8.673.09% (i.e.
2.26, 4.10 and 2.75 times the standards, respectively). There was
evidence of conversion to osteogenic cells (Fig. 1C, panel f) and fat
vesicles were seen in almost all stimulated cells (Fig. 1C, panel g).
Taken together, these data identify the hBM-MSCs employed in this
study as multipotent progenitor cells potentially suitable for repo-
pulating decellularized matrices in vitro.
3.2. Decellularization and alpha-gal detection
Specimens of p- and hPVLs underwent a double control proce-
dure involving hematoxylin/eosin and Hoechst stainings to reveal
nuclear and cell debris. No nuclei or cell fragments were visible
under light or ﬂuorescence microscopy (Fig. 2, panels A, B, I for
pPVLs and C, D for hPVLs).
Carbohydrate binding protein BSI-B4 and M86 antibody were
both used for alpha-gal epitope visualization in porcine samples.
Compared to the native condition, where these reagents co-stained
Gala1–3Gal (aGal) glycans (Fig. 2, panels E, F and G), isolectin
glycoprotein linked aspeciﬁcally to the ﬁbers of decellularized
matrices (Fig. 2, panels H and J). Immunoﬂuorescence with M86
(considered a more realistic assay for alpha-gal detection) gave
negative results (Fig. 2G).
In all samples, a decrease in leaﬂet thickness was qualitatively
appreciable, possibly due to GAG loss of hexosamine and uronate in
the spongiosa caused by detergent action, as shown in Fig. 3 (and
also reported in other publications by our group [6]).
3.3. Histological and immunohistochemical evaluation of in vitro
tissue-engineered leaﬂets
Fig. 4 shows the qualitative microscopic ﬁndings in porcine
engineered leaﬂets after 30 days of static conditioning with hBM-
MSCs. An examination of histological patterns for porcine ﬁbrosa or
ventricularis cell seeding produced slightly different results: while
an endothelial-like covering (not always continuous) was achieved
in all conditions, cell penetration in the scaffolds was higher in VS
samples, resulting in a fairly homogeneous repopulation of the
three leaﬂet layers (Fig. 4, panels A, C and E for FS; G, I and K for VS).
Masson’s trichrome conﬁrmed these aspects and revealed tissue
thickening in the spongiosa layer (Fig. 4, panels B, D and F for FS; H, J
and L for VS). No signs of calciﬁcation could be appreciated in
seeded leaﬂets (von Kossa’s staining not shown).
Immunohistochemical analysis corroborated the notion that
a proper differentiation of hBM-MSCs into valve-speciﬁc pheno-
types could be achieved in the porcine leaﬂets, i.e. EC, ﬁbroblast and
Fig. 1. Pre-seeding characterization of hBM-MSCs. Cells displayed a spindle-shaped morphology (A; panel a; magniﬁcation 100) with multilayer growth (A; panel b; magniﬁcation
200), typical MSC pattern in cytoﬂuorimetric assay (B, panels a–l) and were able to differentiate into endothelial (C, panels a–b; 400), smooth muscle (C, panels c–e; 400),
osteogenic (C, panel f; 100) and adipogenic (C, panel g; 100) cell lineages.
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Table 1
Immunophenotypic characterization of hBM-MSCs as determined by ﬂow cytom-
etry and on cytocentrifuged cells.
hBM-MSCs before static seeding: ﬂow cytometry and cytocentrifugation
Antigen Percentage of positive cells
CD45 0.39 0.55 /
CD34 0.93 0.44 Negative
CD117 3.06 0.33 Negative
CD133 / Negative
HLA-DR 1.37 0.10 /
HLA-ABC 91.42 0.19 88.21 0.69
MHC II / Negative
CD73 98.03 0.23 /
CD105 99.74 0.34 /
CD29 95.74 5.49 95.93 3.57
CD44 93.33 3.92 /
CD90 95.94 0.28 90.63 2.44
Stro1 / 22.66 6.64
GFAP / 16.38 1.96
Nestin / 27.14 3.52
NGFr / 31.78 1.36
SSEA4 / 26.44 16.39
OCT3/4 / 32.18 3.68
CD146 76.74 11.14 /
CD54 / 40.30 4.33
Flk1 / 27.58 1.58
Vimentin / 90.74 8.49
SM aactin / 9.14 0.83
MyHC-Apla2 / 30.79 2.81
MyHC-Apla1 / 40.32 6.85
SM22 / 15.43 2.04
SM-MyHC / 3.15 0.28
Smoothelin / Negative
CD31 0.67 0.29 /
vWf / 16.25 2.73
Pro-collagen I / 38.88 7.96
Aggrecan / 31.65 5.47
Osteopontin / 33.10 1.11
Osteocalcin / Negative
Osteonectin / Negative
Tenascin / Negative
Values (means SD, in %) were obtained from three different sets of experiments.
/¼not tested.
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expression of fully differentiated SMC proteins, such as SM-MyHC.
This approach also enabled adhesion, phenotypic distribution,
proliferative capacity and apoptotic events, that hBM-MSCs can
undergo, to be evaluated. Porcine FS demonstrated a lower cell-
attracting potential than VS counterparts (see Table 2 for a detailed
quantitative analysis). Cell spreading, estimated by counting
Hoechstþ cells, was greater in VS- than in FS-pPVLs (p< 0.01).
Differences in phenotypic conversion were noted for the endothe-
lial markers CD31 (p< 0.01) and vWf (p¼NS). Apart from a MyHC-
Apla1
þ ﬁbroblastic phenotype displayed by the vast majority of cells
(p¼NS), the expression of proteins of smooth muscle lineage, such
as SM22, SM a-actin and SM-MyHC, varied: it was signiﬁcant for
the last two, and for VS in particular (Fig. 5, panels A, C, E and G for
FS, and B, D, F and H for VS). There was also evidence of a process of
matrix element formation involving pro-collagen I and aggrecan
cellular synthesis (p¼NS; not shown). Importantly, some cells still
expressed the stem markers SSEA4 (p¼NS) and OCT3/4 (p< 0.01).
The expression of osteopontin and osteocalcin (marker of calcifying
cells) differed between FS and VS, but not to any signiﬁcant degree.
The capacity for survival of hBM-MSCspopulating porcine leaﬂets
was also studied. Proliferating, phospho-histone H3þ cells were
found in both tissues, but in higher numbers inVS than in FS (p¼NS),
while the opposite situation was seen among cells embarking on an
apoptotic program (p¼NS).
We decided then to mimic an in vivo ‘‘xenogeneic’’ vs. ‘‘alloge-
neic’’ setting by testing in vitro the potential of hBM-MSC coloniz-ation for porcine (fresh) and human (cryopreserved) decellularized
VS (Table 2). By comparison with pig VS specimens, the corre-
sponding human ones revealed a greater cell adhesion (p< 0.01;
see Fig. 6, panels A and B), with no evidence of histopathological
changes (Fig. 6C). With regard to the phenotypic conversion,
a higher number of cells expressed EC markers, such as von Wil-
lebrand factor (p¼NS) and CD31 (p< 0.01). Fibroblast protein
MyHC-Apla1 was well represented by the homotypically-seeded
cells (p¼NS) (Fig. 6D). Among these ﬁbroblast-like cells, there
were contractile elements positive for SM a-actin (p¼NS) and
SM22 (p< 0.01; Fig. 6E and F), with a greater smooth muscle
differentiation (p< 0.01), as determined from the distribution of
SM-MyHCþ cells in the ventricularis (Fig. 6, panel G and inset H).
Pro-collagen I and aggrecan production did not seem to diverge
signiﬁcantly from the heterotypic VS combination. Osteopontin-
positive cells increased, while osteocalcin-expressing elements
diminished (for both p¼NS). The markers of pluripotency, SSEA4
and OCT3/4, persisted in a limited cell number (p¼NS). In the
‘‘allogeneic setting’’, there was a superior proliferation (p< 0.01)
accompanied by a lower apoptosis index (p< 0.01).
3.4. Ultrastructural analysis
Additional information on the differentiation proﬁle of adhered
hBM-MSCs was obtained by analyzing ultrathin sections of engi-
neered valve leaﬂets. Repopulated PVLs of human origin (from
cryopreserved valves; Fig. 7) and from porcine tissue (from fresh
specimens; Fig. 8) exhibited well-preserved ECM ﬁbrous compo-
nents, i.e. collagen ﬁbrils retained their typical D-band pattern,
unaffected by the consequences of degradation, such as swelling or
shrinkage (Figs. 7A–C, F–I; 8A–D). No clearly distorted/disrupted
elastin ﬁbers or ﬁbrillin microﬁbrils were encountered, while the
presence of occasional fragments might correlate with minimal
degradation of the ﬁbroelastic valve supporting network.
Monolayers of ﬂat endothelium-like cells, lacking in basal
lamina, covered ample areas of ventricularis and ﬁbrosa, (Figs. 7A, B;
8A–D), but lay in close proximity with an amorphous, ﬂocculent
layer resembling the basal lamina of the original endothelium cells,
possibly retained during valve treatment with detergents. This was
more evident when nude leaﬂet areas were observed (Fig. 7C). In
endothelialized regions, most of these cells were interconnected by
mature tight junctions (Fig. 7B) or immature cell junctions (Fig. 8A),
showing caveolae or clathrin-coated endocytic pits at basal plasma
membrane level (Fig. 8B and C).
Fibroblast-like cells interspersed within the matrix scaffolds
were often endowed with abundant rough endoplasmic reticulum
(Figs. 7D and 8D), that was frequently composed of dilated
cisternae (Fig. 7E), and well-developed Golgi apparatuses (Fig. 8E).
In addition, cells engaged in active collagen ﬁbrillogenesis, as
shown by the presence of numerous so-called ‘‘ﬁbril-forming
channels’’ [21,22], were also detectable. These extracellular
compartments were (1) located within both cell bodies and cell
processes, (2) shaped as single ﬁbril-containing narrow channels or
wider tubular recesses containing two or more ﬁbrils, and (3) co-
axially arranged (Fig. 7F). Early, electrondense elastin ﬁbers sur-
rounded by ﬁbrillin-microﬁbrils were also observed (Fig. 7G). In the
cytoplasm of other ﬁbroblast-like cells, thin bundles of microﬁla-
ments and immature intercellular junctions (Fig. 7H), reminiscent
of ongoing myoﬁbroblast differentiation, were also visible. Finally,
several interstitium-populating cells were characterized by an
elongated shape and revealed developing intercellular junctions
and clathrin-coated pits as well as abundant bundles of co-oriented
microﬁlaments and mitochondria (Figs. 7G; 8E and F), thus
resembling nearly mature SMCs, even if short basal lamina tracts
were only detectable on their surfaces.
Fig. 2. Decellularization test and alpha-gal detection. Removal of cell debris, both cellular and nuclear, was studied in pig and human leaﬂet specimens using hematoxylin and eosin
and Massons trichrome (panels A–B for porcine samples and C–D for human ones; magniﬁcation 320). In porcine tissues, alpha-gal epitopes were revealed by double immu-
noﬂuorescence with BSI-B4 isolectin and M86 antibody; in native conditions, double-positive elements could be appreciated both in the endothelial lining and in some interstitial
cells (E–G, magniﬁcation 400); after decellularization, BSI-B4 revealed a speciﬁc binding to matrix ﬁbers, while M86 revealed no reactivity (H–J, magniﬁcation 400).
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the immunohistochemical ﬁndings, i.e. the phenotypic potential
of hBM-MSCs for ﬁbro-myoﬁbroblast, EC- and SMC-like cell
transitions.
4. Discussion
A bioengineered valve that relies on the multipotent differen-
tiation potential of hBM-MSCs could be the best choice for the
complete repopulation of natural or artiﬁcial scaffolds suitable forsuccessfully valvular substitutions. In fact, our in vitro analysis of
how competent hBM-MSCs are for this task, prior to their in vivo
application in an animal model, has shown that these cells can
indeed differentiate, after stimulation (Fig. 1C) or direct contact
with matrix elements (Figs. 5–8, and Table 2), into appropriate
valve cell lineages (ﬁbroblasts, myoﬁbroblasts, SMCs and ECs) [4,7].
hBM-MSCs display a repertoire of molecules that may be relevant
to their adhesion and penetration in decellularized scaffolds (see
Fig. 1B and Table 1), including b1-integrin (which plays a pivotal
role by mediating cell–ECM interactions) and CD54, CD105 and
Fig. 3. Tissue analysis on pPVLs. Essential matrix ﬁbers were well-preserved as shown by histology and immunohistochemistry for collagen I, collagen III and elastin (magniﬁcation
65).
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luronan, the major non-protein glycosaminoglycan of the ECM [23],
the main components of which (pro-collagen I and aggrecan) are
also synthesized by hBM-MSCs).
Although such properties are inherent in these cells in vitro, the
efﬁciency of their attachment and survival when seeded on the
matrix, andsubsequently transplanted into ananimalmodel, is likely
to depend ultimately on the ﬁbrous supporting network and its
associated molecules. The in vitro observed dissimilarities in prolif-
erationanddifferentiationpatterns inﬁbrosavs. ventricularis settings
could be related to regional differences in blood pressure/volumewhich concern the ascendant aortic wall [24]. Though these gradi-
ents do not have the same magnitude in the pulmonary circulation,
a similar ﬂow behaviour is reported for both right and left outﬂow
tracts, where the different ﬂuid mechanics on the ventricular vs.
artery side inﬂuences the local distribution of the main ECM
constituents (elastin and collagens), as well as the least represented
proteins (laminin and ﬁbronectin) [24]. In fact, the proteoglycans
versican, decorin and biglycan have a signiﬁcantly higher combina-
torial distribution in the ventricularis with a decreasing staining
intensity towards the ﬁbrosa, while hyaluronan is strongly expressed
in the spongiosa. This layer-speciﬁc distribution reﬂects properly the
Fig. 4. FS vs. VS procedures. hBM-MSCs, statically seeded on the ventricularis layer (blue line), were better able to adhere and spread in the spongiosa interstitium than cells on the
ﬁbrosa one (red line; magniﬁcation 320).
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function played in this respect by each ECM element, i.e. the
compressive resistance offered by hyaluronan, the critical roles per-
formed by decorin and biglycan in tension and elastogenesis and yet
the important contribution of decorin in collagenﬁbrillogenesis [25].
In this regard, Sales and colleagues [26] investigated the effects
produced by different protein precoatings of elastomeric biomate-
rials (glycerol sebacate) on EPC phenotypic regulation. Coating withTable 2
Quantitative analysis on in vitro tissue-engineered heart valve leaﬂets.
hBM-MSCs statically seeded onto p- and hPVLs: Repopulation, valve cell phenotypic con
FS-pPVLs VS-pPVLs
Adhered cells
Total cell nuclei 473.11 46.13 622.40 43.05
Differentiating cells
EC markers
CD31 204.99 24.72 285.20 15.44
vWf 222.82 23.46 276.29 18.38
Fibroblast marker
MyHC-Apla1 463.46 5.82 525.85 46.73
SMC proteins
SM a-actin 134.43 39.23 197.56 33.74
SM22 169.34 28.20 204.99 38.63
SM-MyHC – 49.91 4.08
ECM synthesis
Pro-collagen I 212.82 45.92 285.20 12.23
Aggrecan 285.20 6.88 311.94 40.31
Stem cell markers
SSEA4 62.37 32.02 142.60 19.98
OCT3/4 17.83 6.17 37.43 5.35
Other cell components
Osteopontin 338.68 15.37 347.59 46.31
Osteocalcin 17.63 6.73 11.39 2.67
Proliferating cells
Phospho-Histone H3 97.06 25.94 150.53 17.38
Apoptotic cells
Apoptag 86.90 18.98 60.16 11.50
For each parameter, values represent the number of positive cells per mm2, expressed as m
VS- hPVLs, respectively. –¼ negative; NS¼ not signiﬁcant.ﬁbronectin, collagen types I/III or elastin drives the differentiation of
engrafted EPCs towards a heterogeneous antigenic proﬁle in CD31,
vWf and SM a-actin expression. Among the various experimental
conditions tested, elastin-precoated scaffolds notably show a higher
cellularity when colonized with these cells and this result is consis-
tentwith our ﬁndingof an additional SM-like differentiation of hBM-
MSCs in the elastin-rich ventricularis. By enzymatic decellularization
anddynamic seedingwith ovine arterial cells, Schenke-Layland et al.version and capacity for survival after 30 days
VS-hPVLs p1 p2
768.72 47.45 p< 0.01 p< 0.01
356.51 15.68 p< 0.01 p< 0.01
329.77 30.61 NS NS
570.41 38.44 NS NS
190.88 42.06 p< 0.01 NS
338.68 24.26 NS p< 0.01
124.78 30.87 p< 0.01 p< 0.01
231.73 27.20 NS NS
309.98 14.90 NS NS
178.25 33.62 NS NS
50.80 14.15 p< 0.01 NS
383.24 40.84 NS NS
6.48 3.17 NS NS
190.91 25.67 NS p< 0.01
43.58 10.96 NS p< 0.01
eanþ SD. p1 and p2 refer to p values between FS- and VS- pPVLs and VS- pPVLs and
Fig. 5. Immunohistochemical analysis on FS (red line) and VS (blue line) porcine specimens. Proteins of the contractile apparatus were detectable among ﬁbroblasts in both
treatments, especially in VS specimens (magniﬁcation 65).
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the ventricularis of engineered porcine pulmonary valve leaﬂets [27].
Elastic ﬁbers, which are insoluble in the valvular ECM, consist of
macromolecules of cross-linked elastin surrounded by ﬁbrillin-rich
microﬁbrils, containing theRGDcell adhesionmotif,which is capable
of interacting with cell integrins, thus regulating cytoskeleton reor-
ganization, cell proliferation and synthetic activities [28]. VGVAPG
hexapeptide in tropoelastin is also able to induce similar phenotypic
changes bypromoting a proliferating smoothmuscle commitment in
ﬁbroblasts, ECs, chondrocytes and, even, in contractile vascular SMCs
[29,30]. In the hetero- vs. homotypic cell seeding onto decellularized
porcine and human valve leaﬂets, an even greater potential for SMC
andECdifferentiation is achievedwhenhBM-MSCsare applied in thehomotypic combinationwith the ventricularis side of the pulmonary
leaﬂets, suggesting, here again, that this particular matrix expresses
local conditions to favour the appropriate cell conversion for this
valve layer, i.e. myoﬁbroblasts and SMCs. Occasionally, such pheno-
typic conversions seemtobe incomplete inasmuchas somestemcell
markers persist along with proteins of SMC lineage among the
homing hBM-MSCs. It thus seemsmore appropriate to identify such
cells as SMC-like cells, since it is hard to say whether this pattern is
transient or permanent. In the process of ECM architectural recon-
structionoperatedbyhBM-MSCsespecially intohumanmatrices, it is
noteworthy that – even by static conditioning – some cells are
priming anovel collagenﬁbrillogenesis (Table 2 andFig. 7F). Actually,
the formation of collagen ‘‘ﬁbril-forming channels’’, substantiating
Fig. 6. The ‘‘allogeneic’’ setting of engineered cell-to-matrix leaﬂets. hBM-MSCs were seeded onto the ventricularis layer of hPVLs with a good repopulation proﬁle and no
calciﬁcation events, as seen in serial tissue sections (A–C; magniﬁcation 65). Typical valve markers were analyzed: ﬁbroblast and myoﬁbroblast epitopes were revealed in all three
leaﬂet layers MyHC-Apla1, SM22 and SM-Actin (D–F; magniﬁcation 65). SM-MyHC, expressed by differentiated and mature SMCs, was rightly present in the ventricularis amid
elastic ﬁbers (G, magniﬁcation 65 and in H, magniﬁcation 320).
L. Iop et al. / Biomaterials 30 (2009) 4104–4116 4113the synthesis of new pro-collagen components, nearly recapitulates
the mechanism by which ﬁbroblasts regulate the morphogenetic
steps in embryonic tissues [21,22]. Completely achieving the fully
differentiated cell phenotype demands, however, a speciﬁc local
milieu for cell growth, possibly containing a suitable cocktail of
growth factors, with prolonged culture times and appropriate
biomechanical stimulation [31].
Less certain is the interpretation of the differential colonizing
potential observed in the ‘‘xenogeneic’’ (hBM-MSCs andporcine fresh
PVLs) and ‘‘allogeneic’’ (hBM-MSCs and human cryopreserved PVLs)
combinations, being potentially attributable to decellularization
effects on treated matrices. Most collagen ﬁbrils and elastic ﬁbers
exhibit well-preserved ultrastructural features (Figs. 7 and 8) –
a situation consistent with our previous results [4–6] – therefore the
gross distribution of collagen and elastin is left unchanged with
respect to the native ECM [32]. These ultrastructural patterns are also
conﬁrmed for thehumancryopreserved specimens (Fig. 7), in striking
contrast with previous studies for which cryopreservation has been
reported to cause severe alterations, including disintegration of most
collagenous structures of cryopreserved porcine pulmonary roots
[33]. However, other consequences of the decellularizing treatment,
i.e. thepartial lossofglycosaminoglycansandchondroitinsulphate [6]
and the possible differential extraction of ECM components from
porcine (fresh) vs. human (cryopreserved) valve leaﬂets, might alter
the stabilization of the tertiary and quaternary structures of some
ECMmacromolecular aggregates. Further experiments are needed to
establish whether the preparation of fresh porcine leaﬂets mayrequire additional treatment with detergents to get rid of ‘‘contami-
nating’’ protein residues compared with human specimens. Though
we cannot rule out the possibility of traces of residual proteins
released by detergent washout of VICs persisting in decellularized
matrices, the fact that no calciﬁcation clusters or deposits are visible
after culturing our cell–scaffold constructs would support the
conviction that most of the cellular debris has been removed.
Given the scarcity of organ donations, it will be more and more
necessary to rely on the readily available animal organs to create new
valve alternatives. The structural and functional resemblance of
porcine and human heart valves has led to the pig being chosen as
the ideal donor for bioprostheses. Tissue-engineered constructs
from allogeneic or xenogeneic valve scaffolds covered with autolo-
gous, multipotent progenitor cells are considered the new frontier
for valve replacement. Until now, adverse immune reactions to valve
substitutes from (glutaraldehyde-ﬁxed) xenogeneic or allogeneic
scaffolds have been attributed to cellular components of heart valves
(for instance, alpha-gal epitopes expressed by porcine endothelial
cells [34]), or to the glutaraldehyde [35]. For future applications in
this ﬁeld, it therefore appears promising that our scaffolds are
immunohistochemically devoid of alpha-gal antigens (Fig. 2G). On
the other hand, it may be that detergent procedures used for heart
valve decellularization could affect the antigenic stability of the
collagen-elastic matrix (or induce cryptic epitopes) in scaffolds from
xeno- and (to a lesser extent) allogeneic donors [36–38]. Ongoing
studies at our laboratory on immunocompetent and immunodeﬁ-
cient rats transplanted with intact or decellularized porcine leaﬂets
Fig. 7. Ultrastructural analysis on bioengineered hPVLs. (A) Endothelium-like cell adhering to the stromal surface on the ﬁbrosa layer; note the retention of preserved collagen ﬁbril
bundles. Magniﬁcation 3000. (B) Wide tight junction (arrowheads) between two endothelium-like cells; notice the pentalayered membrane (inset). Magniﬁcation 27,000; inset
43,000. (C) An acellular tract of ﬁbrosa; note coating with a layer resembling basal lamina (double arrows) and inner D-banded collagen ﬁbrils. Magniﬁcation 28,000. (D) RER in
a ﬁbroblast-like cell (asterisks). Magniﬁcation 35,000. (E) RER dilated cisternae in a ﬁbroblast-like cell (asterisks). Magniﬁcation 80,000. (F) A ﬁbroblast-like cell; observe co-axial
collagen ﬁbril-forming channels and cytoplasmic processes. Inset: seven adjacent channels containing one collagen ﬁbril and a two-ﬁbril-containing channel. Magniﬁcation
25,000; inset 48,000. (G) Electrondense elastin ﬁbers surrounded by ﬁbrillin-microﬁbrils (f). Magniﬁcation 30,000. (H) Immature intercellular junction between two interstitial
cells (arrowheads) within a framework of unaltered collagen ﬁbril bundles (C). Magniﬁcation 5000. (I) Co-oriented bundles of microﬁlaments (mf) in an elongated interstitial cell;
clathrin-coated pits (asterisks). E: an elastin ﬁber surrounded by ﬁbrillin-microﬁbrils. Magniﬁcation 17,000.
L. Iop et al. / Biomaterials 30 (2009) 4104–41164114
Fig. 8. Ultrastructural analysis on engineered pPVLs. (A) Immature intercellular junction (arrowhead) between two endothelium-like cells covering ventricularis; cf collagen ﬁbrils;
fm: ﬁbrillin microﬁbrils. Magniﬁcation 75,000. (B) Presence of caveolae (arrowheads) along the basal plasmalemma of an endothelium-like cell; cf D-banded collagen ﬁbrils; fm:
ﬁbrillin microﬁbrils. Magniﬁcation 23,000. (C) Clathrin-coated pits (asterisks) and caveolae (arrowheads) along the basal plasmalemma of an endothelium-like cell; cf D-banded
collagen ﬁbrils. Magniﬁcation 23,000. (D) Presence of RER (asterisks) in an interstitial cell; C: collagen ﬁbril bundle. Magniﬁcation 10,500. (E) Two developing intercellular
junctions between two interstitial cells, the lower one resembling a smooth muscle cell; G: Golgi apparatus; mf: microﬁlaments. Magniﬁcation 27,000. (F) Bundles of micro-
ﬁlaments (mf) in an interstitial cell. Magniﬁcation 26,000.
L. Iop et al. / Biomaterials 30 (2009) 4104–4116 4115and type I collagen patches in the peritoneum cavity suggest that
treatment with detergents makes the valve matrix more immuno-
genic, probably due to ﬁne molecular alterations of the ECM system
(publication in preparation). Using in vitro assays, Rieder et al.
ascertained that decellularized porcine pulmonary valve conduits
are able to attract more monocytic cells than their human counter-
parts [39]. The same group also demonstrated that human poly-
morphonuclear leukocyte activation, subsequent to the contact of
decellularized porcine matrices with human plasma, can be blocked
by inhibitory elements extracted in the decellularization process
[40], thus suggesting that an appropriate matching of the host
(scaffold) to the donor (patient’ s cells) is of paramount importance
for the successful outcome of tissue engineering experiments.
In such a scenario, the realization of autologous, vital and long-
lasting tissue-engineered heart valves likely passes through thedevelopment of functionally ‘‘humanized’’ xenogeneic matrices in
which an in vivo potential xeno-reaction might be prevented by
biomimetic strategies, as the one provided by masking porcine
antigens with human ECM components yielded by patient’s
hBM-MSCs.
5. Conclusion
The inherent suitability of hBM-MSCs as an efﬁcient cell source for
experimental and clinical applications in cardiac valve tissue engi-
neering was demonstrated in vitro, once stimulated with differenti-
ation media or after homing in porcine and human valve scaffolds.
The results of this study also indicate that such acellular ECM
matrices, achieved with a non-enzymatic decellularization proce-
dure,may have an impact on the colonization capacity of hBM-MSCs,
L. Iop et al. / Biomaterials 30 (2009) 4104–41164116as demonstrated by the fact that: (1) the two anisotropic micro-
structures of ventricularis and ﬁbrosa from porcine pulmonary valve
leaﬂets behave differently as regards cell proliferation, differentiation
and survival; and that (2) the homotypic cell seeding onto decellu-
larized human matrix is more effective than its heterotypic
counterpart.
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